1. Home
  2. AR vs AXSM Comparison

AR vs AXSM Comparison

Compare AR & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Antero Resources Corporation

AR

Antero Resources Corporation

HOLD

Current Price

$33.69

Market Cap

10.8B

Sector

Energy

ML Signal

HOLD

Logo Axsome Therapeutics Inc.

AXSM

Axsome Therapeutics Inc.

HOLD

Current Price

$251.17

Market Cap

12.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AR
AXSM
Founded
2002
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.8B
12.0B
IPO Year
2013
2015

Fundamental Metrics

Financial Performance
Metric
AR
AXSM
Price
$33.69
$251.17
Analyst Decision
Buy
Strong Buy
Analyst Count
16
17
Target Price
$47.13
$211.12
AVG Volume (30 Days)
4.4M
592.3K
Earning Date
04-29-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
1027.78
38.56
EPS
1.72
N/A
Revenue
$5,275,823,000.00
N/A
Revenue This Year
$29.74
$57.24
Revenue Next Year
$5.07
$55.88
P/E Ratio
$19.72
N/A
Revenue Growth
21.97
N/A
52 Week Low
$29.10
$96.09
52 Week High
$45.75
$257.93

Technical Indicators

Market Signals
Indicator
AR
AXSM
Relative Strength Index (RSI) 37.47 70.67
Support Level $32.86 $148.87
Resistance Level $35.68 N/A
Average True Range (ATR) 1.01 8.33
MACD -0.17 0.51
Stochastic Oscillator 7.71 86.66

Price Performance

Historical Comparison
AR
AXSM

About AR Antero Resources Corporation

Antero Resources is an exploration and production firm whose operations represent a pure play in the Marcellus Shale, located in northern West Virginia. The company started in 2002 as an E&P focused on the Barnett Shale (Fort Worth, Texas). Antero redefined itself in Appalachia's Marcellus Shale in 2005. In 2012, shortly before Antero's 2013 IPO, Antero Midstream Partners was formed to handle the company's rapidly growing gas volumes. In 2026, the firm narrowed its focus further by selling its Ohio Utica assets and using the proceeds to acquire additional Marcellus acreage from HG Energy. Just over half of its production and earning power is tied to natural gas, with the remainder mostly NGLs, where it holds a leading position, and some crude oil.

About AXSM Axsome Therapeutics Inc.

Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.

Share on Social Networks: